HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke

Glass laboratory flasks on light table

Hiroshima University started the human trial for a promising treatment that offers hope in potentially reversing paralysis and language disorder after moderate to severe stroke using therapeutically superior mesenchymal stem cells (MSCs) derived from the cranial bone.

Pandemic-related stressors have physically altered teens’ brains, study shows

Previous article

Parler wants you to know its deal with Kanye West is off

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News